These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20214326)

  • 21. Infantile Presentation of Leber Hereditary Optic Neuropathy "Plus" Disease.
    Zakrzewski H; Modabber M; Wilson N; Al-Hertani W; Toffoli D
    J Neuroophthalmol; 2019 Jun; 39(2):249-252. PubMed ID: 30829945
    [No Abstract]   [Full Text] [Related]  

  • 22. Idebenone for Leber's hereditary optic neuropathy.
    Gueven N
    Drugs Today (Barc); 2016 Mar; 52(3):173-81. PubMed ID: 27186591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial.
    Newman NJ; Biousse V; Newman SA; Bhatti MT; Hamilton SR; Farris BK; Lesser RL; Turbin RE
    Am J Ophthalmol; 2006 Jun; 141(6):1061-1067. PubMed ID: 16765674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of idebenone on color vision in patients with leber hereditary optic neuropathy.
    Rudolph G; Dimitriadis K; Büchner B; Heck S; Al-Tamami J; Seidensticker F; Rummey C; Leinonen M; Meier T; Klopstock T
    J Neuroophthalmol; 2013 Mar; 33(1):30-6. PubMed ID: 23263355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Never too old: late-onset Leber hereditary optic neuropathy.
    Vincent SJ; Lowe KA; Monsour CS
    Clin Exp Optom; 2018 Jan; 101(1):137-139. PubMed ID: 28281297
    [No Abstract]   [Full Text] [Related]  

  • 26. Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy.
    Klopstock T; Metz G; Yu-Wai-Man P; Büchner B; Gallenmüller C; Bailie M; Nwali N; Griffiths PG; von Livonius B; Reznicek L; Rouleau J; Coppard N; Meier T; Chinnery PF
    Brain; 2013 Feb; 136(Pt 2):e230. PubMed ID: 23388409
    [No Abstract]   [Full Text] [Related]  

  • 27. Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study.
    Sadun AA; Salomao SR; Berezovsky A; Sadun F; Denegri AM; Quiros PA; Chicani F; Ventura D; Barboni P; Sherman J; Sutter E; Belfort R; Carelli V
    Trans Am Ophthalmol Soc; 2006; 104():51-61. PubMed ID: 17471325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery.
    Hsu TK; Wang AG; Yen MY; Liu JH
    Clin Exp Optom; 2014 Jan; 97(1):84-6. PubMed ID: 23905692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial abnormalities in patients with LHON-like optic neuropathies.
    Abu-Amero KK; Bosley TM
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4211-20. PubMed ID: 17003408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset Leber hereditary optic neuropathy.
    Pfeiffer ML; Hashemi N; Foroozan R; Lee AG
    Clin Exp Ophthalmol; 2013; 41(7):690-3. PubMed ID: 23433437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A teenager with acute bilateral visual loss].
    Ødegaard EM; Jørstad ØK; Kerty E
    Tidsskr Nor Laegeforen; 2018 Aug; 138(12):. PubMed ID: 30132618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical features of Leber's hereditary optic neuropathy with the 11778 mitochondrial DNA mutation in Taiwanese patients.
    Hung HL; Kao LY; Huang CC
    Chang Gung Med J; 2003 Jan; 26(1):41-7. PubMed ID: 12656308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy.
    Carelli V; Carbonelli M; de Coo IF; Kawasaki A; Klopstock T; Lagrèze WA; La Morgia C; Newman NJ; Orssaud C; Pott JWR; Sadun AA; van Everdingen J; Vignal-Clermont C; Votruba M; Yu-Wai-Man P; Barboni P
    J Neuroophthalmol; 2017 Dec; 37(4):371-381. PubMed ID: 28991104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in visual acuity using low vision devices in patients with Leber hereditary optic neuropathy: A retrospective study.
    Gopalakrishnan S; Bhaskaran G; Jayasankar O; Selvakumar A; Raman R
    Indian J Ophthalmol; 2023 Feb; 71(2):402-407. PubMed ID: 36727327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idebenone: A Review in Leber's Hereditary Optic Neuropathy.
    Lyseng-Williamson KA
    Drugs; 2016 May; 76(7):805-13. PubMed ID: 27071925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What are the characteristics and progression of visual field defects in patients with Leber hereditary optic neuropathy: a prospective single-centre study in China.
    Liu HL; Yuan JJ; Tian Z; Li X; Song L; Li B
    BMJ Open; 2019 Mar; 9(3):e025307. PubMed ID: 30878986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Leber hereditary optic neuropathy.
    Newman NJ
    Brain; 2011 Sep; 134(Pt 9):2447-50. PubMed ID: 21859767
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence of the primary LHON mutations in Northern Finland associated with bilateral optic atrophy and tobacco-alcohol amblyopia.
    Korkiamäki P; Kervinen M; Karjalainen K; Majamaa K; Uusimaa J; Remes AM
    Acta Ophthalmol; 2013 Nov; 91(7):630-4. PubMed ID: 22970697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in multifocal visual evoked potentials during the acute phase of Leber's hereditary optic neuropathy.
    Gränse L
    Acta Ophthalmol Scand; 2006 Aug; 84(4):549-51. PubMed ID: 16879580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?
    Mashima Y; Kigasawa K; Wakakura M; Oguchi Y
    J Neuroophthalmol; 2000 Sep; 20(3):166-70. PubMed ID: 11001192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.